Holiday Shopping: St. Jude Adds To A-Fib, Cardio Units With Two Acquisitions
This article was originally published in The Gray Sheet
St. Jude Medical acquired two privately-held firms just before the New Year for a total of $550 million, gaining tools for artery lesion assessment and precise interventional procedure navigation, among other technologies
You may also be interested in...
Abbott And Coroventis Partner To Address Often-Overlooked Microvascular Dysfunction
Coroventis’ CoroFlow software allows Abbott’s PressureWire X to diagnose coronary microvascular dysfunction caused by invisible blockages in the heart’s smallest arteries.
New Products In Brief
Debuts include DexCom’s G4 Platinum continuous glucose monitor, OraSure’s OraQuick in-home HIV test and St. Jude’s MediGuide 3D navigation system for cardiovascular procedures.
Abbott Can Sell St. Jude’s Intravascular Assessment Tools Under Expanded Alliance
Rights for Abbott to promote and distribute intravascular optical coherence tomography imaging and fractional flow reserve products from St. Jude Medical are added to an existing co-promotion pact between the firms.